Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 133
Filtrar
1.
Artigo em Inglês | MEDLINE | ID: mdl-38470507

RESUMO

PURPOSE: This systematic review (SR) of SRs evaluates the effectiveness of vasopressin alone or in combination with other drugs in improving the outcomes of cardiac arrest (CA). METHODS: Using a three-step approach, we searched five databases to identify all relevant SRs. Two reviewers independently selected suitable studies, assessed study quality, and extracted relevant data. If an outcome was reported by multiple SRs, a re-meta-analysis was conducted as needed; otherwise, a narrative analysis was performed. RESULTS: Twelve SRs covering 16 original studies were included in this review. The meta-analysis results revealed a significant increase in survival to hospital admission for patients with in-hospital CA (IHCA) or out-of-hospital CA (OHCA) receiving vasopressin alone compared with that for those receiving epinephrine alone. Furthermore, the return of spontaneous circulation (ROSC) was significantly increased in patients with OHCA receiving vasopressin with epinephrine compared with that in those receiving epinephrine alone. Compared with patients with IHCA receiving epinephrine with placebo, those receiving vasopressin, steroids, and epinephrine (VSE) exhibited significant increases in ROSC, survival to hospital discharge, favorable neurological outcomes, mean arterial pressure, renal failure-free days, coagulation failure-free days, and insulin requirement. CONCLUSION: VSE is the most effective drug combination for improving the short- and long-term outcomes of IHCA. It is recommended to use VSE in patients with IHCA. Future studies should investigate the effectiveness of VSE against OHCA and CA of various etiologies, the types and standard dosages of steroids for cardiac resuscitation, and the effectiveness of vasopressin-steroid in improving CA outcomes.

2.
Photosynth Res ; 157(1): 1-11, 2023 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-36856939

RESUMO

Chloroplasts are double membrane bound organelles that are found in plants and algae. Their division requires a number of proteins to assemble into rings along the center of the organelle and to constrict in synchrony. Chloroplasts possess a third membrane system, the thylakoids, which house the majority of proteins responsible for the light-dependent reactions. The mechanism that allows chloroplasts to sort out and separate the intricate thylakoid membrane structures during organelle division remain unknown. By characterizing the sizes of thylakoids found in a number of different chloroplast division mutants in Arabidopsis, we show that thylakoids do not divide independently of the chloroplast division cycle. More specifically, we show that thylakoid division requires the formation of both the inner and the outer contractile rings of the chloroplast.


Assuntos
Proteínas de Arabidopsis , Arabidopsis , Tilacoides/metabolismo , Arabidopsis/genética , Arabidopsis/metabolismo , Cloroplastos/metabolismo , Organelas/metabolismo , Proteínas de Arabidopsis/genética , Proteínas de Arabidopsis/metabolismo , Plantas/metabolismo
3.
Am J Dermatopathol ; 45(8): 532-538, 2023 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-37377278

RESUMO

ABSTRACT: Alopecia is common in Jamaican, primarily Afro-Caribbean patients. We performed a retrospective review examining the histopathologic alopecia diagnoses over ∼5 years. Requisition forms and pathology reports were assessed. Demographic/clinical/technical/diagnostic and pathologic findings of chronicity/severity data were recorded. Three hundred thirty-eight biopsies were included. The majority were 4 mm punches, grossed horizontally. The F:M ratio was 4.8:1, mean age = 42.7 years, and mean duration of alopecia = 5.1 years. Cicatricial alopecias (CAs) predominated over non-CAs (NCAs). The top 10 diagnoses were central centrifugal CA (21.9%), folliculitis decalvans (10.9%), multifactorial alopecias (10.1%), pattern hair loss (8%), lichen planopilaris (7.1%), alopecia areata (6.2%), discoid lupus erythematosus (6.2%), nonclassifiable lymphocytic scarring alopecias (5.6%), frontal fibrosing alopecia (5.3%), and nonspecific NCAs (5%). This contrasted with other richly pigmented populations where discoid lupus erythematosus predominates. Other interesting findings included relatively frequent folliculitis decalvans and lichen planus pigmentosus in 40.9% of frontal fibrosing alopecia cases. Scarring/nonscarring clinicopathologic congruence occurred in 83.4%.Regarding histopathologic features of severity/chronicity, CAs had markedly decreased hair counts. Perifollicular fibrosis affecting retained hairs occurred in 75% of CAs, moderate to severe in >50% of these. Approximately 50% of NCA samples demonstrated advanced miniaturization (T:V ratio <2:1). In our study, relatively young women with chronic hair loss and CA are most frequently biopsied. Central centrifugal CA is the most common diagnosis. Local features of chronic/severe disease are seen microscopically. Clinical impression of scarring/nonscarring correlates well with histopathology.


Assuntos
Alopecia em Áreas , Foliculite , Líquen Plano , Lúpus Eritematoso Discoide , Humanos , Feminino , Adulto , Cicatriz/patologia , Jamaica/epidemiologia , Alopecia/patologia , Lúpus Eritematoso Discoide/patologia , Líquen Plano/patologia , Foliculite/patologia
4.
Am J Gastroenterol ; 117(8): 1221-1230, 2022 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-35509128

RESUMO

INTRODUCTION: Antimicrobial resistance among Helicobacter pylori strains has been rising globally, leading to declining eradication rates. We performed a systematic review and meta-analysis of the resistance patterns of H. pylori strains in the United States between 2011 and 2021. METHODS: Ovid MEDLINE, Embase, CINAHL, and Cochrane CENTRAL databases were searched for manuscripts and conference abstracts published between 2011 and 2021 reporting H. pylori antibiotic resistance. A mixed-effects model estimated pooled rates of resistance to clarithromycin, amoxicillin, metronidazole, tetracycline, rifabutin, levofloxacin, or a combination of these, with 95% confidence intervals (CIs). RESULTS: A total of 19 studies including 2,660 samples, met inclusion criteria. The pooled rate of resistance to metronidazole was 42.1% (95% CI 27.3%-58.6%), levofloxacin 37.6% (95% CI 26.3%-50.4%), clarithromycin 31.5% (95% CI 23.6%-40.6%), amoxicillin 2.6% (95% CI 1.4%-5.0%), tetracycline 0.87% (95% CI 0.2%-3.8%), rifabutin 0.17% (95% CI 0.00%-10.9%), and dual clarithromycin and metronidazole 11.7% (95% CI 0.1%-94.0%). Considerable data heterogeneity was evident for pooled resistance prevalence rates (I 2 > 50%), with the exception of rifabutin resistance. DISCUSSION: Metronidazole, levofloxacin, and clarithromycin resistance rates each exceed 30%; thus, choosing an empiric antibiotic regimen without knowledge of the likely pattern of antibiotic resistance is not appropriate. Resistance to tetracycline, rifabutin, and amoxicillin remains low. Given the scarcity of available data with considerable heterogeneity among studies, continued surveillance, ideally with a more systematic approach to data collection, is an increasingly important goal in H. pylori management.


Assuntos
Infecções por Helicobacter , Helicobacter pylori , Amoxicilina , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Claritromicina , Farmacorresistência Bacteriana , Resistência Microbiana a Medicamentos , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/epidemiologia , Humanos , Levofloxacino/farmacologia , Levofloxacino/uso terapêutico , Metronidazol/farmacologia , Metronidazol/uso terapêutico , Rifabutina , Tetraciclina/farmacologia , Tetraciclina/uso terapêutico , Estados Unidos/epidemiologia
5.
J Vasc Surg ; 76(5): 1354-1363.e1, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-35709858

RESUMO

BACKGROUND: The objective of the present study was to categorize the presentation and treatment of acute limb ischemia (ALI) in young patients and compare the adverse outcomes after revascularization compared with that of older patients. METHODS: All the patients who had presented to a multi-institution healthcare system with ALI from 2016 to 2020 were identified. The presenting features, operative details, and outcomes were included in the present analysis. Patients with existing peripheral arterial disease (acute on chronic) were analyzed separately from those without (de novo thrombosis or embolus). Within these groups, younger patients (age, ≤50 years) were compared with older patients (age, >50 years). The 3-month major adverse limb event-free survival was the primary outcome. RESULTS: A total of 232 patients (age, 60 ± 16 years; 44% female sex, 87% white race) were included in the analysis. Of the 232 patients, 119 were in the acute on chronic cohort and 113 were in the de novo thrombosis/embolism cohort. Age did not affect the overall outcomes (P = .45) or the outcomes for the acute on chronic group (P = .17). However, in the de novo thrombosis/embolism cohort, patients aged ≤50 years had worse major adverse limb event-free survival compared with patients aged >50 years (hazard ratio, 2.47; 95% confidence interval, 1.08-5.68; P = .03) after adjustment for Rutherford class, interval from presentation to the operating room, and smoking status. In the de novo thrombosis/embolism group, the operative approach was similar across the age groups (endovascular, 12% vs 14%; open, 48% vs 41%; hybrid, 41% vs 45%; P = .78). In the younger patients, embolism was more likely from a proximal arterial source (71%). In contrast, in the older patients, the source of embolism was more often a cardiac source (86%). The rates of hypercoagulable disease were equal across the age groups (10% vs 10%; P = .95). The In-hospital mortality was 3% overall (acute on chronic, 5%; de novo, 3%). CONCLUSIONS: Despite advances in interventional options, for patients with ALI due to de novo thrombosis or embolus, younger age was associated with worse short-term limb-related outcomes.


Assuntos
Embolia , Procedimentos Endovasculares , Doença Arterial Periférica , Trombose , Humanos , Feminino , Pessoa de Meia-Idade , Adulto , Idoso , Masculino , Salvamento de Membro , Extremidade Inferior/irrigação sanguínea , Amputação Cirúrgica , Procedimentos Endovasculares/efeitos adversos , Fatores de Risco , Resultado do Tratamento , Doença Aguda , Fatores de Tempo , Isquemia/diagnóstico , Isquemia/cirurgia , Doença Arterial Periférica/diagnóstico , Doença Arterial Periférica/terapia , Embolia/etiologia , Trombose/terapia , Trombose/cirurgia , Estudos Retrospectivos
6.
Am J Dermatopathol ; 44(12): 904-912, 2022 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-36395447

RESUMO

ABSTRACT: Plexiform neurofibromas are benign neural tumors observed in association with neurofibromatosis. Isolated lesions exist. We conducted a systematic review of the published literature indexed in the PubMed/Medline database using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Thirty-five studies describing isolated plexiform neurofibromas were included detailing 41 tumors. Isolated lesions occur in all age groups, in both sexes and in all races. Cutaneous and mucosal lesions were reported. Asymptomatic, slowly enlarging masses were the most common clinical presentation, but lesions could be painful. Trauma-associated lesions were uncommon, but reported. Histopathologic features were similar to syndromic counterparts, but well-circumscribed/encapsulated lesions, rare association with diffuse neurofibroma, lack of reported malignant degeneration, and rare named-nerve origin were observed. Excision was curative in many cases, but recurrence could occur. Plexiform neurofibromas occur without neurofibromatosis in a subset of patients with isolated tumors.


Assuntos
Neurofibroma Plexiforme , Neurofibroma , Neurofibromatose 1 , Masculino , Feminino , Humanos , Neurofibroma Plexiforme/patologia , Neurofibroma/patologia , Neurofibromatose 1/patologia , Pele/patologia
7.
J Immunol ; 202(1): 56-68, 2019 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-30510068

RESUMO

Perivascular accumulation of lymphocytes can be a prominent histopathologic feature of various human inflammatory skin diseases. Select examples include systemic sclerosis, spongiotic dermatitis, and cutaneous lupus. Although a large body of work has described various aspects of the endothelial and vascular smooth muscle layers in these diseases, the outer adventitial compartment is poorly explored. The goal of the current study was to characterize perivascular adventitial fibroblast states in inflammatory human skin diseases and relate these states to perivascular lymphocyte accumulation. In normal skin, adventitial fibroblasts are distinguished by CD90 expression, and dense perivascular lymphocytic infiltrates are uncommon. In systemic sclerosis, this compartment expands, but lymphocyte infiltrates remain sparse. In contrast, perivascular adventitial fibroblast expression of VCAM1 is upregulated in spongiotic dermatitis and lupus and is associated with a dense perivascular T cell infiltrate. VCAM1 expression marks transitioned fibroblasts that show some resemblance to the reticular stromal cells in secondary lymphoid organs. Expanded adventitial compartments with perivascular infiltrates similar to the human settings were not seen in the inflamed murine dermis. This species difference may hinder the dissection of aspects of perivascular adventitial pathology. The altered perivascular adventitial compartment and its associated reticular network form a niche for lymphocytes and appear to be fundamental in the development of an inflammatory pattern.


Assuntos
Dermatite/imunologia , Fibroblastos/fisiologia , Inflamação/imunologia , Lúpus Eritematoso Discoide/imunologia , Escleroderma Sistêmico/imunologia , Pele/imunologia , Linfócitos T/imunologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Células Cultivadas , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Antígenos Thy-1/metabolismo , Molécula 1 de Adesão de Célula Vascular/metabolismo , Adulto Jovem
8.
Am J Dermatopathol ; 42(8): 571-577, 2020 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-32701691

RESUMO

BACKGROUND: Exogenous ochronosis (EO) is a deposition disease associated with application of hydroquinone-containing preparations. Characteristic ochronotic bodies (OBs) arise from endogenous connective tissues, most often reported as collagen. We highlight a significant role for elastic fibers as a precursor tissue. OBJECTIVE: To evaluate elastic tissue pathology in EO, specifically as it relates a precursor role in ochronotic body formation. METHODS: In this retrospective observational study, a literature review using PubMed/MEDLINE database was conducted to ascertain the most commonly ascribed precursor connective tissue. Eleven histopathologic cases of EO were identified. Patient demographics and clinical characteristics were recorded. Slides were reviewed for the presence and grade of solar elastosis (SE), the relationship of OBs to elastotic material, the presence of elastotic fibers transitioning to OBs, and positivity of bodies with Verhoeff-van Gieson elastic tissue stain. RESULTS: Elastic fibers are uncommonly reported as the major precursor tissue of OBs. SE was uniformly present in our cases, and the majority demonstrated heavy/high-grade elastosis. Elastotic fibers transitioning to OBs were observed in all cases, and the bodies demonstrated Verhoeff-van Gieson positivity. LIMITATIONS: Small sample size. CONCLUSIONS: Ochronotic body formation is associated with SE, and bodies appear to arise from damaged elastic fibers.


Assuntos
Tecido Elástico/patologia , Ocronose/patologia , Humanos , Hidroquinonas/efeitos adversos , Ocronose/induzido quimicamente , Estudos Retrospectivos
9.
J Cardiothorac Vasc Anesth ; 34(2): 521-529, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30765207

RESUMO

This special article presents perspectives on the mentoring of fellows for academic practice in adult cardiothoracic anesthesiology. A comprehensive mentoring model should address the areas of clinical care, educational expertise and exposure to scholarly activity. The additional value of educational exposure to patient safety, quality improvement and critical care medicine in this model is also explored.


Assuntos
Anestesiologia , Tutoria , Adulto , Humanos , Mentores , Estados Unidos
11.
Am J Dermatopathol ; 41(1): 16-28, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30320623

RESUMO

BACKGROUND: CD90 fibroblasts have been described arising from and replacing the homeostatic CD34 network in scleroderma, but have not been specifically examined in other forms of cutaneous fibrosis. OBJECTIVES: To address expression, timelines, and spatial relationships of CD90, CD34, and smooth muscle actin (SMA) expressing fibroblasts in scars and to examine for the presence of a CD34-to-CD90 transition. METHODS: One hundred and seventeen scars (reparative/hypertrophic/keloidal) were evaluated for CD90, CD34, and SMA expression. Double-staining immunohistochemistry for CD90/CD34 was performed to identify CD90/CD34 transitioning cells, confirmed by double-color immunofluorescence. In addition, some scars were double-stained with CD90/SMA, CD90/procollagen-1, or SMA/procollagen-1 to evaluate spatial relationships and active collagen synthesis. Expression was graded as diffuse, minority, and negative. RESULTS: Most scars demonstrate a CD90/CD34 pattern, and dual CD90/CD34 fibroblasts were observed in 91% of scars. In reparative scars, CD90 expression reverses to a CD34/CD90 state with maturation. Pathologic scars exhibit prolonged CD90 expression. Both CD90 and SMA fibroblasts collagenize scars, although CD90 fibroblasts are more prevalent. CONCLUSIONS: CD90 fibroblasts likely arise from the resting CD34 fibroblastic network. Actively collagenizing scar fibroblasts exhibit a CD90/CD34 phenotype, which is prolonged in pathologic scars. CD90 fibroblasts are likely important players in cutaneous scarring.


Assuntos
Antígenos CD34/metabolismo , Cicatriz Hipertrófica/metabolismo , Fibroblastos/metabolismo , Queloide/metabolismo , Regeneração , Pele/metabolismo , Antígenos Thy-1/metabolismo , Actinas/metabolismo , Biomarcadores/metabolismo , Cicatriz Hipertrófica/patologia , Colágeno Tipo I/metabolismo , Fibroblastos/patologia , Fibrose , Imunofluorescência , Humanos , Queloide/patologia , Miofibroblastos/metabolismo , Miofibroblastos/patologia , Fenótipo , Pró-Colágeno/metabolismo , Pele/patologia , Fatores de Tempo
12.
Heart Surg Forum ; 22(2): E124-E130, 2019 03 08.
Artigo em Inglês | MEDLINE | ID: mdl-31013222

RESUMO

BACKGROUND: Advanced age is a relative contraindication for heart transplantation, but no age cutoff has been defined for patients receiving mechanical circulatory support. METHODS: Between November 1, 2003 and November 1, 2012, we implanted the HeartMate II (HMII) left ventricular assist device (LVAD) in 319 patients. One hundred seven patients (89 men, 18 women) were over 60 years old (mean, 66 ± 4 years, range, 61-78 years) and received the HMII as a bridge to transplantation (n = 45) or as destination therapy (n = 62). We evaluated their experience by performing a retrospective analysis. RESULTS: Seventy-two patients had ischemic cardiomyopathy, and 34 had idiopathic cardiomyopathy. Three patients (2.8%) already had a HeartMate XVE LVAD, 54 (50.5%) were receiving intra-aortic balloon pump support, 52 (48.6%) had undergone a previous cardiac procedure, and 9 (8.4%) had received renal replacement therapy (RRT) (continuous venovenous hemofiltration, hemodialysis, or both) before HMII implantation. The median duration of HMII support was 313 days (range, 1-3339 days). After device implantation, 36 patients (33.6%) had gastrointestinal bleeding, 24 (23%) required RRT, 18 (17.5%) had ventricular arrhythmias, and 24 (22.4%) had LVAD-related infections, and 9 (8.4%) had right ventricular failure requiring mechanical support, and 28 (26.2%) had neurologic complications. The actual survival rate was 69% at 6 months, 63% at 1 year, and 54% at 2 years. Eighty-one patients died, 9 are still receiving HMII support, and 17 are alive after heart transplantation. CONCLUSIONS: Older patients can benefit from LVAD therapy, and advanced age should not preclude LVAD implantation.


Assuntos
Cardiomiopatias/cirurgia , Insuficiência Cardíaca/cirurgia , Coração Auxiliar , Disfunção Ventricular Esquerda/cirurgia , Idoso , Cardiomiopatias/mortalidade , Feminino , Insuficiência Cardíaca/mortalidade , Transplante de Coração , Humanos , Balão Intra-Aórtico , Masculino , Pessoa de Meia-Idade , Desenho de Prótese , Terapia de Substituição Renal , Estudos Retrospectivos , Taxa de Sobrevida , Disfunção Ventricular Esquerda/mortalidade
13.
J Cutan Pathol ; 45(11): 855-857, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30022508

RESUMO

There exists a spectrum of solar elastotic variants based on the clinical and histopathologic findings. We present here a peculiar case of solar elastosis that is unusual in its anatomic location, relative lack of background actinic damage, and pattern of linearization. Its presentation suggests that other factors in addition to ultraviolet radiation may play a role in the pathogenesis of solar elastosis.


Assuntos
Tecido Elástico/patologia , Envelhecimento da Pele/patologia , Idoso , Feminino , Humanos
14.
Dermatol Ther ; 31(1)2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-28976625

RESUMO

Disseminated superficial actinic porokeratosis (DSAP) is the most common variant of porokeratosis with a potential for malignant transformation. Its association with malignant melanoma, however, is exceedingly rare. Treatment of DSAP is often ineffective. We report a unique case of amelanotic melanoma arising within a lesion of DSAP. The melanoma was managed surgically, and her DSAP were treated successfully with a novel approach utilizing 5-fluorouracil chemowraps.


Assuntos
Antimetabólitos Antineoplásicos/administração & dosagem , Transformação Celular Neoplásica , Fluoruracila/administração & dosagem , Melanoma Amelanótico/cirurgia , Poroceratose/tratamento farmacológico , Lesões Pré-Cancerosas/tratamento farmacológico , Neoplasias Cutâneas/cirurgia , Administração Cutânea , Idoso , Bandagens , Biópsia , Transformação Celular Neoplásica/patologia , Feminino , Humanos , Melanoma Amelanótico/patologia , Poroceratose/diagnóstico , Lesões Pré-Cancerosas/diagnóstico , Neoplasias Cutâneas/patologia , Resultado do Tratamento
17.
Dermatol Online J ; 24(1)2018 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-29469768

RESUMO

Pseudoainhum is a rare constriction band variant thatmay progress to spontaneous digital strangulationand auto-amputation. Although its association withpalmoplantar keratodermas is well established, ithas not been reported in conjunction with classicepidermolytic ichthyosis. We describe the first suchcase in a 25-year-old woman who presented witha painful constricting band of the fifth toe. We alsodescribe her treatment course, which consisted ofa failed z-plasty, the traditional therapeutic optionfor acute pseudoainhum, and report the success ofsubsequent full thickness skin graft, suggesting thebenefit of this procedure as a therapeutic alternativefor patients with pseudoainhum.


Assuntos
Ainhum/cirurgia , Constrição Patológica/cirurgia , Hiperceratose Epidermolítica/complicações , Transplante de Pele , Pele/patologia , Adulto , Ainhum/complicações , Ainhum/patologia , Constrição Patológica/complicações , Constrição Patológica/patologia , Feminino , Humanos , Hiperceratose Epidermolítica/patologia , Procedimentos de Cirurgia Plástica , Reoperação , Falha de Tratamento
18.
Neuroophthalmology ; 42(5): 326-333, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30258481

RESUMO

The 33rd Asia-Pacific Academy of Ophthalmology (APAO) Congress was held on Feb 8-11, 2018 in Hong Kong. This report summarized the highlights of the neuro-ophthalmology program of the Congress, including the scientific symposia (invited and submitted) and the social activities.

19.
J Cutan Pathol ; 44(10): 898-902, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28628256

RESUMO

Luteinized thecomas with sclerosing peritonitis (LTSP) is a rare disease characterized by ovarian luteinized thecomas and associated fibrosing peritonitis. Cutaneous involvement has never been reported. We report a case of classical LTSP with skin involvement, outlining the clinical and histopathologic features of this novel presentation of a rare syndrome.


Assuntos
Neoplasias Ovarianas , Peritonite , Neoplasias Cutâneas , Tumor da Célula Tecal , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias Ovarianas/metabolismo , Neoplasias Ovarianas/patologia , Peritonite/metabolismo , Peritonite/patologia , Neoplasias Cutâneas/metabolismo , Neoplasias Cutâneas/patologia , Síndrome , Tumor da Célula Tecal/metabolismo , Tumor da Célula Tecal/patologia
20.
J Cutan Pathol ; 44(11): 969-973, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28796338

RESUMO

Epidermodysplasia verruciformis (EV) is a genodermatosis characterized by overgrowth of flat warts, pityriasis versicolor-like lesions and an increased propensity for developing cutaneous squamous cell carcinomas due to abnormal susceptibility to infection with beta-human papilloma viruses. Adnexal tumors are not typically associated with EV. Here we report a spectrum of hybrid adnexal tumors with divergent eccrine and folliculosebaceous differentiation, and cytologic features ranging from benign to frankly atypical, in a patient with inherited EV.


Assuntos
Epidermodisplasia Verruciforme/complicações , Neoplasias de Anexos e de Apêndices Cutâneos/patologia , Neoplasias de Anexos e de Apêndices Cutâneos/virologia , Carcinoma de Células Escamosas/virologia , Humanos , Masculino , Neoplasias Primárias Múltiplas/virologia , Neoplasias Cutâneas/virologia , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA